These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 37954576)

  • 1. RIPK1 and RIPK3 inhibitors: potential weapons against inflammation to treat diabetic complications.
    Ke D; Zhang Z; Liu J; Chen P; Dai Y; Sun X; Chu Y; Li L
    Front Immunol; 2023; 14():1274654. PubMed ID: 37954576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects and mechanisms of total flavones of Abelmoschus manihot in inhibiting podocyte necroptosis and renal fibrosis in diabetic kidney disease].
    Chen JX; Fang QJ; Wan YG; Liu YL; Wang Y; Wu W; Tu Y; Wang MZ; Wang DG; Ge HT
    Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(15):4137-4146. PubMed ID: 37802782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of cardiac fibroblasts.
    Qiao S; Hong L; Zhu Y; Zha J; Wang A; Qiu J; Li W; Wang C; An J; Zhang H
    Cell Death Dis; 2022 Feb; 13(2):147. PubMed ID: 35165268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High glucose-induced apoptosis and necroptosis in podocytes is regulated by UCHL1 via RIPK1/RIPK3 pathway.
    Xu Y; Gao H; Hu Y; Fang Y; Qi C; Huang J; Cai X; Wu H; Ding X; Zhang Z
    Exp Cell Res; 2019 Sep; 382(2):111463. PubMed ID: 31247189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
    Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
    Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
    Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
    Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors Targeting RIPK1/RIPK3: Old and New Drugs.
    Martens S; Hofmans S; Declercq W; Augustyns K; Vandenabeele P
    Trends Pharmacol Sci; 2020 Mar; 41(3):209-224. PubMed ID: 32035657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy.
    Shi Y; Huang C; Zhao Y; Cao Q; Yi H; Chen X; Pollock C
    Sci Rep; 2020 Jun; 10(1):10458. PubMed ID: 32591618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Wang Z; Feng J; Yu J; Chen G
    J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation regulates RIPK1 activity to limit cell death and inflammation.
    Tu H; Xiong W; Zhang J; Zhao X; Lin X
    Nat Commun; 2022 Nov; 13(1):6603. PubMed ID: 36329033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
    Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3.
    Dillon CP; Weinlich R; Rodriguez DA; Cripps JG; Quarato G; Gurung P; Verbist KC; Brewer TL; Llambi F; Gong YN; Janke LJ; Kelliher MA; Kanneganti TD; Green DR
    Cell; 2014 May; 157(5):1189-202. PubMed ID: 24813850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
    Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
    Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
    Saleh D; Degterev A
    Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the Raf kinase inhibitor TAK-632 and its analogues as potent inhibitors of necroptosis by targeting RIPK1 and RIPK3.
    Chen X; Zhuang C; Ren Y; Zhang H; Qin X; Hu L; Fu J; Miao Z; Chai Y; Liu ZG; Zhang H; Cai Z; Wang HY
    Br J Pharmacol; 2019 Jun; 176(12):2095-2108. PubMed ID: 30825190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.
    Dannappel M; Vlantis K; Kumari S; Polykratis A; Kim C; Wachsmuth L; Eftychi C; Lin J; Corona T; Hermance N; Zelic M; Kirsch P; Basic M; Bleich A; Kelliher M; Pasparakis M
    Nature; 2014 Sep; 513(7516):90-4. PubMed ID: 25132550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
    Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
    Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic function.
    Hänggi K; Vasilikos L; Valls AF; Yerbes R; Knop J; Spilgies LM; Rieck K; Misra T; Bertin J; Gough PJ; Schmidt T; de Almodòvar CR; Wong WW
    Cell Death Dis; 2017 Feb; 8(2):e2588. PubMed ID: 28151480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting RIPK1,2,3 to combat inflammation.
    Bullock AN; Degterev A
    Oncotarget; 2015 Oct; 6(33):34057-8. PubMed ID: 26472031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.